Antiparasitics, insecticides and anti-mite treatments intended for pets should never be used on humans, especially children. Veterinary medicinal products obtain marketing authorisation (MA) prior to marketing based on a risks vs benefits assessment for the animal they are to be used on. If the risks for humans have been identified and evaluated, it is only with regard to the risks for individuals who handle or administer the products. 

In the context of the veterinary drug monitoring plan that ANSES has implemented via the French Agency for Veterinary Medicinal Products,  serious and even lethal adverse reactions in cats treated with topical antiparasitic treatments containing permethrin used for treating dogs are regularly reported. ANSES therefore reminds cat owners to never use permethrin-based veterinary medicinal products on their cats and provides them here with a series of recommendations in order to avoid cat poisonings.